SEMA3B and colorectal carcinoma: Our results demonstrated that SEMA3B‐AS1 was downregulated in CRC cell lines and tissues, and that low SEMA3B‐AS1 expression was connected with TNM stages and poor prognosis of advanced CRC patients significantly.